You are browsing the Hong Kong website, Regulated by Hong Kong SFC (CE number: BJA907). Investment is risky and you must be cautious when entering the market.
東瑞製藥(02348.HK):上半年歸母淨利潤1.05億元 同比減少78.8%

格隆匯8月22日丨東瑞製藥(02348.HK)發佈公告,截至2025年6月30日止六個月,實現收入人民幣6.30億元,同比增加9.2%;毛利爲人民幣3.14億元,同比減少7.1%;母公司擁有人應佔本期間溢利(撇除2024年非經常性溢利包括出售聯營公司收益及設備驗證補助)爲人民幣1.05億元,同比減少17.1%;母公司擁有人應佔溢利爲人民幣1.05億元,同比減少78.8%;基本每股盈利人民幣0.06961元,擬派中期股息每股港幣0.015元。本期間溢利下降主要是蘇州東瑞善豐路廠區和蘭州東瑞未形成規模化的商業化生產、“安”系列等集採品種受國家政策影響部分省份價格下降以及研發費用增加所致。

Follow us
Find us on Facebook, Twitter , Instagram, and YouTube or frequent updates on all things investing.Have a financial topic you would like to discuss? Head over to the uSMART Community to share your thoughts and insights about the market! Click the picture below to download and explore uSMART app!
Disclaimers
uSmart Securities Limited (“uSmart”) is based on its internal research and public third party information in preparation of this article. Although uSmart uses its best endeavours to ensure the content of this article is accurate, uSmart does not guarantee the accuracy, timeliness or completeness of the information of this article and is not responsible for any views/opinions/comments in this article. Opinions, forecasts and estimations reflect uSmart’s assessment as of the date of this article and are subject to change. uSmart has no obligation to notify you or anyone of any such changes. You must make independent analysis and judgment on any matters involved in this article. uSmart and any directors, officers, employees or agents of uSmart will not be liable for any loss or damage suffered by any person in reliance on any representation or omission in the content of this article. The content of the article is for reference only and does not constitute any offer, solicitation, recommendation, opinion or guarantee of any securities, virtual assets, financial products or instruments. Regulatory authorities may restrict the trading of virtual asset-related ETFs to only investors who meet specified requirements. Any calculations or images in the article are for illustrative purposes only.
Investment involves risks and the value and income from securities may rise or fall. Past performance is not indicative of future performance. Please carefully consider your personal risk tolerance, and consult independent professional advice if necessary.
uSMART
Wealth Growth Made Easy
Open Account